Results 31 to 40 of about 5,279 (205)

Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review

Frontiers in Psychiatry, 2022
BackgroundSchizophrenia is considered one of the major risk factors for mortality from SARS-CoV-2 infection. Early antiviral treatment is important to decrease the risk of mortality.
Chun-I Liu, Kah Kheng Goh, Kah Kheng Goh, Kah Kheng Goh, Chun-Hsin Chen, Chun-Hsin Chen, Chun-Hsin Chen   +6 more
doaj   +1 more source

Paxlovid–tacrolimus drug–drug interaction caused severe diarrhea that induced combined diabetic ketoacidosis and a hyperglycemic hyperosmolar state in a kidney transplant patient: a case report

Journal of Medical Case Reports, 2023
Background Transplant recipients are at high risk of coronavirus disease 2019, and a timely supply of antivirals should be prioritized for those patients.
Wei Luo, Yu He, Mao Gang Wei, Guang Bing Lu, Qun Yi   +4 more
doaj   +1 more source

Paxlovid-Induced Symptomatic Bradycardia and Syncope

Cureus, 2023
Paxlovid (nirmatrelvir/ritonavir) is a game changer in the fight against COVID-19 due to its ease of administration and significant benefits of reducing progression to severe COVID-19, hospitalization, and death. Cardiac adverse events such as bradycardia and syncope are not known with this medication.
Ganipisetti, Venu M, Bollimunta, Pratyusha, Maringanti, Sriram   +2 more
openaire   +2 more sources

The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial

Frontiers in Medicine, 2022
ObjectiveTo evaluate the efficacy of Paxlovid in treating Chinese elder patients infected with SARS-CoV-2 omicron variants.Materials and methodsWe performed a non-randomized, controlled trial in Shanghai, China.
Weijie Zhong, Xiufeng Jiang, Xiaosheng Yang, Tiantong Feng, Zhixin Duan, Wei Wang, Zhaoliang Sun, Lingyan Chen, Xin Nie, Chuanlong Zhu, Wenchuan Zhang, Yi Li   +11 more
doaj   +1 more source

Risks of paxlovid in a heart transplant recipient

The Journal of Heart and Lung Transplantation, 2023
The burden of morbidity and mortality from SARS-CoV-2 infection is especially significant in heart transplant patients who are at higher risk for poor outcomes owing to immunosuppression, blunted response to vaccination, and multiple comorbid conditions.
Kristin Stawiarski, Robin Avery, Sara Strout, Priya Umapathi   +3 more
openaire   +2 more sources

Serotonin Syndrome Precipitated by Paxlovid Initiation

Cureus, 2023
A female in her early 40s taking buspirone, quetiapine, and daily kratom presented to the emergency department two days after starting a course of Paxlovid for a mild COVID-19 infection with diffuse tremors, ocular clonus, diaphoresis, and confusion consistent with serotonin syndrome (SS).
Nasser, Nicholas G, Welsh, Connor, Mitra, Avir, Swan, Matthew   +3 more
openaire   +2 more sources

A Rare Case of Paxlovid-Induced Pancreatitis

Cureus, 2023
Acute pancreatitis can result secondary to an inflammatory cascade due to an insult to the pancreatic parenchyma, whether it be from infections, medications, etc. We present a case of a 37-year-old male with acute pancreatitis after being started on Paxlovid, a combination drug containing Nirmatrelvir and Ritonavir, for COVID-19 treatment.
Zaidi, Syed Muhammad Hussain, Iskander, Peter A, Ahmed, Khalid, Jaber, Fouad, Paz, Merlin, Khan, Ali, Malik, Fahad, Aloysius, Mark M   +7 more
openaire   +2 more sources

Paxlovid. Chinese

, 2021
Title from PDF caption (viewed on January 4, 2022)."OHA4029B12292021 SIMPLIFIED CHINESE"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core   +1 more source

Absolute Risk Reductions in COVID-19 Antiviral Medication Clinical Trials

Pharmacoepidemiology, 2023
COVID-19 antiviral medications approved or authorized for emergency use by the U.S. Food and Drug Administration are reported to have high efficacy in preventing severe illness, hospitalizations, and deaths.
Ronald B. Brown
doaj   +1 more source

Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study

Frontiers in Pharmacology, 2022
Background: Our previous studies have shown that Yindan Jiedu granules (YDJDG) can effectively treat coronavirus disease 2019 (COVID-19); however, the high infectivity and the immune escape potential of the Omicron variant BA.2 make it more difficult to ...
Ying Feng, Yao Liu, Long Liu, Yao Liu, Yuyong Jiang, Yixin Hou, Yang Zhou, Rui Song, Xiaoyou Chen, Xianbo Wang   +9 more
doaj   +1 more source